CytomX Therapeutics, Inc. (CTMX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $5k
- Jun 15 · No plan
- Form 4 sales
- 135
- On record
- Form 144 notices
- 1
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJun 16, 2025 2025
Sold 12,255 shares at $2.72 ($33k)
Ogden Christopher, Chief Financial Officer
No 10b5-1 planSold 5.1% of holdings ($650k position)226,271 shares left4.9x usual sizeFiling
- 2 Form 144 noticeNoticeNov 6, 2025 +143 days
Filed to sell 101,793 shares ($462k)
McCarthy Sean A., CEO
10b5-1 plan5x usual sizeFiling
- 3 Form 4 saleUnusualNov 6, 2025 same day
Sold 101,793 shares at $4.54 ($462k)
McCarthy Sean A., CEO
10b5-1 planSold 9.3% of holdings ($4.9M position)987,891 shares left5x usual sizeFollows a Form 144Filing
- 4 Form 4 saleUnusualMar 17, 2026 +131 days
Sold 19,323 shares at $6.42 ($124k)
Ogden Christopher, Chief Financial Officer
No 10b5-1 planSold 6.1% of holdings ($2M position)296,948 shares left3.4x usual sizeFiling
- 5 Form 4 saleNo planMar 17, 2026 same day
Sold 31,492 shares at $6.42 ($202k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 9.5% of holdings ($2.1M position)300,760 shares left2.4x usual sizeFiling
- 6 Form 4 saleUnusualMar 17, 2026 same day
Sold 118,969 shares at $6.42 ($764k)
McCarthy Sean A., CEO
10b5-1 planSold 9.9% of holdings ($7.7M position)1.1M shares left3.2x usual sizeFiling
- 7 Form 4 saleNo planMar 17, 2026 same day
Sold 21,279 shares at $6.42 ($137k)
Chu Yu-Waye, Chief Medical Officer
No 10b5-1 planSold 10.1% of holdings ($1.4M position)189,446 shares leftFiling
- 8 Form 4 saleNo planJun 15, 2026 +90 days
Sold 1,624 shares at $3.05 ($5k)
Ogden Christopher, Chief Financial Officer
No 10b5-1 planSold 0.5% of holdings ($906k position)295,324 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (136)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17, 2026 | Ogden Christopher | Chief Financial Officer | Form 4 sale | 1,624 | $5k | 0.5% | No plan | SEC |
| Mar 17, 2026 | Mar 19, 2026 | Chu Yu-Waye | Chief Medical Officer | Form 4 sale | 21,279 | $137k | 10.1% | No plan | SEC |
| Mar 17, 2026 | Mar 19, 2026 | McCarthy Sean A. | CEO | Form 4 sale | 118,969 | $764k | 9.9% | Unusual | SEC |
| Mar 17, 2026 | Mar 19, 2026 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 31,492 | $202k | 9.5% | No plan | SEC |
| Mar 17, 2026 | Mar 19, 2026 | Ogden Christopher | Chief Financial Officer | Form 4 sale | 19,323 | $124k | 6.1% | Unusual | SEC |
| Nov 6, 2025 | Nov 10, 2025 | McCarthy Sean A. | CEO | Form 4 sale | 101,793 | $462k | 9.3% | Unusual | SEC |
| Nov 6, 2025 | Nov 6, 2025 | McCarthy Sean A. | CEO | Form 144 notice | 101,793 | $462k | Notice | SEC | |
| Jun 16, 2025 | Jun 17, 2025 | Ogden Christopher | Chief Financial Officer | Form 4 sale | 12,255 | $33k | 5.1% | Unusual | SEC |
| Jun 16, 2025 | Jun 17, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 13,884 | $37k | 4.9% | Unusual | SEC |
| Jun 16, 2025 | Jun 17, 2025 | McCarthy Sean A. | CEO | Form 4 sale | 55,511 | $149k | 4.8% | Unusual | SEC |
| Mar 18, 2025 | Mar 20, 2025 | McCarthy Sean A. | CEO | Form 4 sale | 37,656 | $23k | 3.6% | No plan | SEC |
| Mar 18, 2025 | Mar 20, 2025 | Ogden Christopher | Chief Financial Officer | Form 4 sale | 8,551 | $5k | 4.1% | Unusual | SEC |
| Mar 18, 2025 | Mar 20, 2025 | Chu Yu-Waye | Chief Medical Officer | Form 4 sale | 4,025 | $2k | 2.9% | No plan | SEC |
| Mar 18, 2025 | Mar 20, 2025 | Rowland Lloyd A | General Counsel | Form 4 sale | 10,203 | $6k | 7.8% | No plan | SEC |
| Mar 18, 2025 | Mar 20, 2025 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 19,512 | $12k | 7.3% | Unusual | SEC |
| Aug 20, 2024 | Aug 22, 2024 | Landau Jeffrey B | Chief Business Officer | Form 4 sale | 4,181 | $5k | 3.4% | No plan | SEC |
| Aug 20, 2024 | Aug 22, 2024 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 4,181 | $5k | 2.3% | No plan | SEC |
| Aug 20, 2024 | Aug 22, 2024 | Rowland Lloyd A | General Counsel | Form 4 sale | 4,181 | $5k | 3.1% | No plan | SEC |
| Aug 20, 2024 | Aug 22, 2024 | Ogden Christopher | Chief Financial Officer | Form 4 sale | 1,984 | $2k | 1.8% | No plan | SEC |
| Aug 20, 2024 | Aug 22, 2024 | McCarthy Sean A. | CEO | Form 4 sale | 13,898 | $17k | 2.1% | No plan | SEC |
| Mar 19, 2024 | Mar 21, 2024 | Rowland Lloyd A | General Counsel | Form 4 sale | 5,268 | $11k | 4.3% | No plan | SEC |
| Mar 19, 2024 | Mar 21, 2024 | McCarthy Sean A. | CEO | Form 4 sale | 20,223 | $42k | 3.7% | No plan | SEC |
| Mar 19, 2024 | Mar 21, 2024 | Ogden Christopher | SVP, Finance and Accounting | Form 4 sale | 2,971 | $6k | 3.4% | No plan | SEC |
| Mar 19, 2024 | Mar 21, 2024 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 12,795 | $27k | 7.1% | No plan | SEC |
| Mar 19, 2024 | Mar 21, 2024 | Landau Jeffrey B | Chief Business Officer | Form 4 sale | 6,562 | $14k | 5.6% | No plan | SEC |
| Dec 20, 2023 | Dec 22, 2023 | McCarthy Sean A. | CEO | Form 4 sale | 13,551 | $19k | 2.9% | No plan | SEC |
| Dec 20, 2023 | Dec 22, 2023 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 4,077 | $6k | 2.6% | No plan | SEC |
| Dec 20, 2023 | Dec 22, 2023 | Landau Jeffrey B | Chief Business Officer | Form 4 sale | 4,077 | $6k | 4.5% | No plan | SEC |
| Dec 20, 2023 | Dec 22, 2023 | Rowland Lloyd A | General Counsel | Form 4 sale | 4,077 | $6k | 4.0% | No plan | SEC |
| Dec 20, 2023 | Dec 22, 2023 | Ogden Christopher | SVP, Finance and Accounting | Form 4 sale | 1,990 | $3k | 3.9% | No plan | SEC |
| Sep 22, 2023 | Sep 22, 2023 | Belvin Marcia | SVP, Chief Scientific Officer | Form 4 sale | 4,119 | $5k | 2.7% | No plan | SEC |
| Sep 22, 2023 | Sep 22, 2023 | Landau Jeffrey B | Chief Business Officer | Form 4 sale | 4,119 | $5k | 5.1% | No plan | SEC |
| Sep 22, 2023 | Sep 22, 2023 | McCarthy Sean A. | CEO | Form 4 sale | 14,601 | $19k | 3.3% | No plan | SEC |
| Sep 22, 2023 | Sep 22, 2023 | Rowland Lloyd A | General Counsel | Form 4 sale | 5,486 | $7k | 6.4% | No plan | SEC |
| Mar 16, 2023 | Mar 20, 2023 | Ogden Christopher | SVP, Finance and Accounting | Form 4 sale | 516 | $1k | 1.3% | No plan | SEC |
| Mar 16, 2023 | Mar 20, 2023 | McCarthy Sean A. | CEO | Form 4 sale | 7,121 | $13k | 1.8% | No plan | SEC |
| Mar 16, 2023 | Mar 20, 2023 | Campoy Carlos | Chief Financial Officer | Form 4 sale | 1,748 | $3k | 4.4% | No plan | SEC |
| Mar 16, 2023 | Mar 20, 2023 | Rowland Lloyd A | General Counsel | Form 4 sale | 2,037 | $4k | 2.8% | No plan | SEC |
| Mar 16, 2023 | Mar 20, 2023 | Landau Jeffrey B | Chief Financial Officer | Form 4 sale | 1,477 | $3k | 2.1% | No plan | SEC |
| Mar 16, 2023 | Mar 20, 2023 | Peterson Amy C. | EVP, Chief Development Officer | Form 4 sale | 4,257 | $8k | 6.8% | No plan | SEC |
| Jul 20, 2022 | Jul 21, 2022 | Peterson Amy C. | EVP, Chief Development Officer | Form 4 sale | 7,463 | $11k | 10.6% | Plan not stated | SEC |
| Jul 20, 2022 | Jul 21, 2022 | Landau Jeffrey B | Chief Business Officer | Form 4 sale | 4,206 | $6k | 12.0% | Plan not stated | SEC |
| Jul 20, 2022 | Jul 21, 2022 | McCarthy Sean A. | President and CEO | Form 4 sale | 14,911 | $21k | 4.9% | Plan not stated | SEC |
| Jul 20, 2022 | Jul 21, 2022 | Rowland Lloyd A | General Counsel | Form 4 sale | 5,602 | $8k | 11.4% | Plan not stated | SEC |
| Jul 20, 2022 | Jul 21, 2022 | Hannah Alison L. | Chief Medical Officer | Form 4 sale | 5,602 | $8k | 14.9% | Plan not stated | SEC |
| Jul 20, 2022 | Jul 21, 2022 | Campoy Carlos | Chief Financial Officer | Form 4 sale | 3,949 | $6k | 9.0% | Plan not stated | SEC |
| Jun 16, 2021 | Jun 21, 2021 | McCarthy Sean A. | President and CEO | Form 4 sale | 100,000 | $704k | 51.8% | Unusual | SEC |
| Mar 31, 2021 | Apr 2, 2021 | McCarthy Sean A. | President and CEO | Form 4 sale | 100,000 | $749k | 32.6% | Unusual | SEC |
| May 12, 2020 | May 14, 2020 | McCarthy Sean A. | President and CEO | Form 4 sale | 36,000 | $540k | 29.9% | Unusual | SEC |
| Dec 12, 2018 | Dec 14, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $45k | 33.6% | Unusual | SEC |
| Nov 2, 2018 | Nov 5, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 6,526 | $98k | 7.4% | Plan not stated | SEC |
| Nov 1, 2018 | Nov 5, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $45k | 33.6% | Unusual | SEC |
| Oct 1, 2018 | Oct 2, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $55k | 33.6% | Unusual | SEC |
| Sep 4, 2018 | Sep 6, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $67k | 33.6% | Unusual | SEC |
| Sep 4, 2018 | Sep 6, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 13,052 | $285k | 13.7% | Plan not stated | SEC |
| Aug 1, 2018 | Aug 2, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $78k | 33.6% | Unusual | SEC |
| Jul 5, 2018 | Jul 9, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 4,497 | $113k | 5.2% | Plan not stated | SEC |
| Jul 3, 2018 | Jul 6, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 2,028 | $51k | 2.4% | Plan not stated | SEC |
| Jul 2, 2018 | Jul 3, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $68k | 33.6% | Unusual | SEC |
| Jul 2, 2018 | Jul 3, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 13,052 | $306k | 13.7% | Plan not stated | SEC |
| Jun 1, 2018 | Jun 5, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $78k | 33.6% | Unusual | SEC |
| May 1, 2018 | May 2, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $80k | 38.8% | Unusual | SEC |
| May 1, 2018 | May 2, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 19,578 | $520k | 80.8% | Unusual | SEC |
| Apr 2, 2018 | Apr 4, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 3,000 | $84k | 38.8% | Unusual | SEC |
| Mar 26, 2018 | Mar 27, 2018 | Gluck Frederick W | Director | Form 4 sale | 5,000 | $160k | 1.8% | Plan not stated | SEC |
| Mar 2, 2018 | Mar 5, 2018 | Gluck Frederick W | Director | Form 4 sale | 16,181 | $485k | 5.5% | Unusual | SEC |
| Mar 2, 2018 | Mar 5, 2018 | Humphrey Rachel | Chief Medical Officer | Form 4 sale | 16,160 | $485k | 34.8% | Unusual | SEC |
| Mar 2, 2018 | Mar 5, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 33,000 | $990k | 87.4% | Unusual | SEC |
| Mar 1, 2018 | Mar 5, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 19,578 | $576k | 80.8% | Unusual | SEC |
| Feb 28, 2018 | Mar 2, 2018 | Humphrey Rachel | Chief Medical Officer | Form 4 sale | 23,840 | $715k | 44.1% | Unusual | SEC |
| Feb 28, 2018 | Mar 2, 2018 | Gluck Frederick W | Director | Form 4 sale | 3,819 | $115k | 1.3% | Plan not stated | SEC |
| Feb 1, 2018 | Feb 2, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,548 | $68k | 35.0% | Unusual | SEC |
| Jan 5, 2018 | Jan 9, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 6,526 | $163k | 58.4% | Unusual | SEC |
| Jan 5, 2018 | Jan 8, 2018 | Gluck Frederick W | Director | Form 4 sale | 10,000 | $250k | 3.3% | Plan not stated | SEC |
| Jan 2, 2018 | Jan 4, 2018 | McCarthy Sean A. | President and CEO | Form 4 sale | 13,052 | $275k | 73.8% | Unusual | SEC |
| Jan 2, 2018 | Jan 3, 2018 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $53k | 25.5% | Unusual | SEC |
| Dec 26, 2017 | Dec 28, 2017 | Gluck Frederick W | Director | Form 4 sale | 5,000 | $111k | 1.6% | Plan not stated | SEC |
| Dec 1, 2017 | Dec 5, 2017 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $51k | 20.3% | Plan not stated | SEC |
| Dec 1, 2017 | Dec 5, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 14,340 | $295k | 75.5% | Unusual | SEC |
| Nov 1, 2017 | Nov 3, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 14,342 | $285k | 77.2% | Unusual | SEC |
| Nov 1, 2017 | Nov 3, 2017 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $50k | 17.1% | Plan not stated | SEC |
| Oct 4, 2017 | Oct 6, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 19,120 | $461k | 81.8% | Unusual | SEC |
| Oct 4, 2017 | Oct 6, 2017 | Kavanaugh William Michael | CSO, Head Res.&Non-Clin. Dev. | Form 4 sale | 48,368 | $1.2M | 77.7% | Unusual | SEC |
| Oct 4, 2017 | Oct 6, 2017 | Gluck Frederick W | Director | Form 4 sale | 10,000 | $243k | 3.1% | Plan not stated | SEC |
| Oct 4, 2017 | Oct 4, 2017 | Tepper Robert I | 10% owner | Form 4 sale | 24,777 | $603k | 45.6% | Unusual | SEC |
| Oct 2, 2017 | Oct 4, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 9,562 | $178k | 69.3% | Unusual | SEC |
| Oct 2, 2017 | Oct 4, 2017 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $45k | 14.6% | Plan not stated | SEC |
| Sep 26, 2017 | Sep 27, 2017 | Gluck Frederick W | Director | Form 4 sale | 5,000 | $87k | 1.5% | Plan not stated | SEC |
| Sep 19, 2017 | Sep 21, 2017 | Tepper Robert I | 10% owner | Form 4 sale | 20,000 | $360k | 26.9% | Unusual | SEC |
| Sep 1, 2017 | Sep 5, 2017 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $43k | 12.7% | Plan not stated | SEC |
| Sep 1, 2017 | Sep 5, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 9,930 | $172k | 70.1% | Unusual | SEC |
| Aug 31, 2017 | Sep 1, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 18,756 | $328k | 81.5% | Unusual | SEC |
| Aug 9, 2017 | Aug 11, 2017 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $38k | 11.3% | Plan not stated | SEC |
| Aug 9, 2017 | Aug 11, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 4,781 | $72k | 53.0% | Unusual | SEC |
| Jul 3, 2017 | Jul 6, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 4,781 | $74k | 53.0% | Unusual | SEC |
| Jul 3, 2017 | Jul 6, 2017 | Ray Debanjan | Chief Financial Officer | Form 4 sale | 2,500 | $39k | 10.2% | Plan not stated | SEC |
| Jun 29, 2017 | Jun 30, 2017 | Tepper Robert I | 10% owner | Form 4 sale | 15,000 | $240k | 25.1% | Unusual | SEC |
| Jun 26, 2017 | Jun 27, 2017 | Gluck Frederick W | Director | Form 4 sale | 5,000 | $73k | 1.5% | Plan not stated | SEC |
| Jun 5, 2017 | Jun 6, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 300 | $5k | 6.6% | Plan not stated | SEC |
| May 1, 2017 | May 2, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 4,781 | $75k | 70.7% | Unusual | SEC |
| Apr 12, 2017 | Apr 14, 2017 | Starr Kevin P | 10% owner | Form 4 sale | 28,357 | $464k | 47.4% | Unusual | SEC |
| Apr 4, 2017 | Apr 5, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 9,562 | $165k | 82.9% | Unusual | SEC |
| Mar 27, 2017 | Mar 27, 2017 | Trv Gp, LLC | 10% owner | Form 4 sale | 1.6M | $28.7M | 24.2% | Plan not stated | SEC |
| Mar 20, 2017 | Mar 21, 2017 | Goeltz II Robert C. | Chief Financial Officer | Form 4 sale | 21,517 | $426k | 68.7% | Unusual | SEC |
| Mar 20, 2017 | Mar 21, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 14,343 | $281k | 87.9% | Unusual | SEC |
| Mar 3, 2017 | Mar 3, 2017 | McCarthy Sean A. | President and CEO | Form 4 sale | 14,343 | $215k | 87.9% | Unusual | SEC |
| Nov 29, 2016 | Dec 1, 2016 | Shannon Timothy M | Director | Form 4 sale | 22,086 | $247k | 0.7% | Plan not stated | SEC |
| Nov 29, 2016 | Dec 1, 2016 | Canaan Partners IX LLC | Director | Form 4 sale | 22,086 | $247k | 0.6% | Plan not stated | SEC |
| Nov 28, 2016 | Nov 28, 2016 | Shannon Timothy M | Director | Form 4 sale | 38,459 | $444k | 1.0% | Plan not stated | SEC |
| Nov 28, 2016 | Nov 28, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 38,459 | $444k | 1.0% | Plan not stated | SEC |
| Nov 22, 2016 | Nov 22, 2016 | Shannon Timothy M | Director | Form 4 sale | 42,550 | $498k | 1.1% | Plan not stated | SEC |
| Nov 22, 2016 | Nov 22, 2016 | Canaan IX L.P. | Director, 10% owner | Form 4 sale | 42,550 | $498k | 1.1% | Plan not stated | SEC |
| Nov 21, 2016 | Nov 21, 2016 | Shannon Timothy M | Director | Form 4 sale | 45,324 | $526k | 1.2% | Plan not stated | SEC |
| Nov 21, 2016 | Nov 21, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 45,324 | $526k | 1.2% | Plan not stated | SEC |
| Nov 16, 2016 | Nov 16, 2016 | Shannon Timothy M | Director | Form 4 sale | 51,581 | $593k | 1.3% | Plan not stated | SEC |
| Nov 16, 2016 | Nov 16, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 51,581 | $593k | 1.3% | Plan not stated | SEC |
| Nov 14, 2016 | Nov 14, 2016 | Shannon Timothy M | Director | Form 4 sale | 86,270 | $963k | 2.2% | Unusual | SEC |
| Nov 14, 2016 | Nov 14, 2016 | Canaan IX L.P. | Director, 10% owner | Form 4 sale | 86,270 | $963k | 2.2% | Plan not stated | SEC |
| Nov 9, 2016 | Nov 10, 2016 | Shannon Timothy M | Director | Form 4 sale | 13,730 | $151k | 0.3% | Plan not stated | SEC |
| Nov 9, 2016 | Nov 10, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 13,730 | $151k | 0.3% | Plan not stated | SEC |
| Jun 10, 2016 | Jun 10, 2016 | Shannon Timothy M | Director | Form 4 sale | 48,427 | $487k | 1.1% | Plan not stated | SEC |
| Jun 10, 2016 | Jun 10, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 48,427 | $487k | 1.1% | Plan not stated | SEC |
| Jun 7, 2016 | Jun 8, 2016 | Shannon Timothy M | Director | Form 4 sale | 111,498 | $1.1M | 2.5% | Unusual | SEC |
| Jun 7, 2016 | Jun 8, 2016 | Canaan IX L.P. | Director, 10% owner | Form 4 sale | 111,498 | $1.1M | 2.5% | Unusual | SEC |
| Jun 3, 2016 | Jun 6, 2016 | Shannon Timothy M | Director | Form 4 sale | 59,621 | $644k | 1.3% | Plan not stated | SEC |
| Jun 3, 2016 | Jun 6, 2016 | Canaan IX L.P. | Director, 10% owner | Form 4 sale | 59,621 | $644k | 1.3% | Plan not stated | SEC |
| Jun 1, 2016 | Jun 2, 2016 | Shannon Timothy M | Director | Form 4 sale | 22,463 | $241k | 0.5% | Plan not stated | SEC |
| Jun 1, 2016 | Jun 2, 2016 | Canaan IX L.P. | Director, 10% owner | Form 4 sale | 22,463 | $241k | 0.5% | Plan not stated | SEC |
| May 27, 2016 | Jun 1, 2016 | Shannon Timothy M | Director | Form 4 sale | 25,082 | $266k | 0.6% | Plan not stated | SEC |
| May 27, 2016 | Jun 1, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 25,082 | $266k | 0.6% | Plan not stated | SEC |
| May 26, 2016 | May 27, 2016 | Shannon Timothy M | Director | Form 4 sale | 51,343 | $531k | 1.1% | Plan not stated | SEC |
| May 26, 2016 | May 27, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 51,343 | $531k | 1.1% | Plan not stated | SEC |
| May 24, 2016 | May 25, 2016 | Shannon Timothy M | Director | Form 4 sale | 13,253 | $134k | 0.3% | Plan not stated | SEC |
| May 24, 2016 | May 25, 2016 | Canaan IX L.P. | Director, 10% owner | Form 4 sale | 13,253 | $134k | 0.3% | Plan not stated | SEC |
| May 20, 2016 | May 23, 2016 | Shannon Timothy M | Director | Form 4 sale | 8,687 | $88k | 0.2% | Plan not stated | SEC |
| May 20, 2016 | May 23, 2016 | Canaan Partners IX LLC | Director, 10% owner | Form 4 sale | 8,687 | $88k | 0.2% | Plan not stated | SEC |